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Abstract
Background: Low-carbohydrate diets in the management of obese patients with type 2 diabetes
seem intuitively attractive due to their potent antihyperglycemic effect.
We previously reported that a 20 % carbohydrate diet was significantly superior to a 55–60 %
carbohydrate diet with regard to bodyweight and glycemic control in 2 non-randomised groups of
obese diabetes patients observed closely over 6 months. The effect beyond 6 months of reduced
carbohydrate has not been previously reported. The objective of the present study, therefore, was
to determine to what degree the changes among the 16 patients in the low-carbohydrate diet
group at 6-months were preserved or changed 22 months after start, even without close follow-
up. In addition, we report that, after the 6 month observation period, two thirds of the patients in
the high-carbohydrate changed their diet. This group also showed improvement in bodyweight and
glycemic control.
Method: Retrospective follow-up of previously studied subjects on a low carbohydrate diet.
Results: The mean bodyweight at the start of the initial study was 100.6 ± 14.7 kg. At six months
it was 89.2 ± 14.3 kg. From 6 to 22 months, mean bodyweight had increased by 2.7 ± 4.2 kg to an
average of 92.0 ± 14.0 kg. Seven of the 16 patients (44%) retained the same bodyweight from 6 to
22 months or reduced it further; all but one had lower weight at 22 months than at the beginning.
Initial mean HbA1c was 8.0 ± 1.5 %. After 6 and 12 months it was 6.6 ± 1.0 % and 7.0 ± 1.3 %,
respectively. At 22 months, it was still 6.9 ± 1.1 %.
Conclusion: Advice on a 20 % carbohydrate diet with some caloric restriction to obese patients
with type 2 diabetes has lasting effect on bodyweight and glycemic control.
Background
We previously reported that 16 obese patients with type 2
diabetes, who were advised to lower their carbohydrate
intake to 20 %, over 6 months achieved significantly bet-
ter control of hyperglycemia and bodyweight than a con-
trol group of similar patients (n = 15), advised to follow
the official dietary guidelines where 55–60 % carbohy-
drate is recommended [1]. We have now reviewed the
clinical charts after 22 months and present the data for the
patients. Since two-thirds of the controls at some point
have changed diet, we report here mainly the results for
the 20 %-carbohydrate group with regard to glycemic con-
trol (HbA1c), bodyweight, body mass index (BMI) (kg/
m2) and lipids after 22 months. We also report HbA1c and
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bodyweight for the 7 patients who immediately switched
to a 20 % carbohydrate diet from the original low-fat diet,
and for whom long-term data is available
Methods
The method has previously been described in detail [1]. In
short, the patients – free of thyroid illness, manifest car-
diac and renal disease – were advised to follow a diet con-
taining initially 1800 kcal for men and 1600 kcal for
women. The proportions of carbohydrates, protein and
fat were 20 %, 30 % and 50 % respectively. The daily
quantity of carbohydrates was 80–90 g. The recom-
mended carbohydrate consumption was limited to vege-
tables and salad. Instead of ordinary bread crisp/hard
bread was recommended, each slice containing 3.5 to 8 g
carbohydrates. Excluded were bread, pasta, potatoes, rice
and breakfast cereals. The patients were counselled to not
eat between meals. It was further recommended that they
walk 30 minutes a day and take a daily multivitamin sup-
plement containing extra calcium. There was an introduc-
tory meeting lasting most of a day. The subjects were then
followed closely for 6 months.
The controls were initially advised on a diet with about
the same caloric content, but the proportions of carbohy-
drates, protein and fat were 55–60 %, 15 % and 25–30 %
respectively [1]. In the normal diabetes diet whole-grain
products are recommended. Generous helpings of vegeta-
bles and several servings of fruits as snacks between meals
are also recommended. As a number of the controls
attended our normal diabetes educational course as intro-
duction to the observation period, the control group on
average received about 50 % more attention – measured
in hours – than the low-carbohydrate group. The controls
then proceeded in the same way as the low-carbohydrate
group.
Seven of the controls switched to a 20 % carbohydrate diet
immediately after the follow-up period. For those we have
data 12–14 months after the change. Three more have
later sought information and have changed diet. We have
no long-term data for those. Five of the original controls
have not changed diet.
All the patients were known to us and visited the diabetes
nurse regularly after the initial period. The same scales
and laboratory were used for all measurements. The
present report is a review of clinical charts. Where a figure
is missing at 22 months we have taken the mean from the
two closest figures. Means are given with standard devia-
tions. T-test for dependent samples is used.
Results
Table 1 shows the measured parameters from start to 22
months.
Bodyweight
The mean weight has increased from month 6 to month
22 by 2.7 ± 4.2 kg. Seven of the 16 patients retained the
same bodyweight from 6 to 22 months or reduced it fur-
ther (See Figure 1).
HbA1c
Initial mean HbA1c for the low carbohydrate group was
8.0 ± 1.5 %. After 6 months the value was 6.6 ± 1.0 % and,
after 12 months, 7.0 ± 1.3 % (normal HbA1c < 5.6 % in
non-diabetic persons).
The mean HbA1c for the group has been stable since the
12 month mark. At 22 months mean HbA1c was 6.9 ± 1.1
% and 4 patients displayed an HbA1c below 6.0 %
whereas initially only one person did so.
The HbA1c reduction occurred independently of the
weight reduction as seen in Figure 2 where the relation-
ship between percentage reduction of weight and HbA1c
after 3 months is shown (r = -0.30).
Medications
An important feature of carbohydrate restriction as a treat-
ment for type 2 diabetes is that reduction or elimination
of medication is often possible [8,21,22]. At the start of
this study, 15 of the 16 patients used metformin and 5 sul-
fonylurea (SU). Eleven patients were insulin-treated. The
mean daily insulin dosage was 60 ± 33 IU/day.
At the end of the 6-months 20 %-carbohydrate period 2
persons had discontinued SU and 3 had reduced the
doses. Three subjects had discontinued insulin and the
mean insulin requirement among the last 8 persons had
fallen to 18 ± 11 IU/day.
Over the next 16 months 2 persons have again started
insulin treatment following an increased intake of carbo-
hydrates. The mean requirement of the 11 persons is 27 ±
21 IU/day.
Fourteen subjects used antihypertensive medications. Five
reduced the medications during the first 6 months and
have not increased them again. The mean blood pressure
has been unchanged. Six of the patients used statins. There
has been no change.
The cross-over of the 7 controls
The 7 controls were followed for 2 periods of 6 months
separated by a gap of 2 months. As shown in Table 2,
reduction of bodyweight and HbA1c in the low-fat period
was 3.5 ± 3.5 kg and 0.9 ± 0.8 % respectively. Both body-
weight and HbA1c increased slightly in the 2 month gap
period but the change to a low-carbohydrate diet led to a
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drate period of 7.5 ± 6.4 kg and of HbA1c of 0.9 ± 1.1 %
(range: 0–2.4). The weight and HbA1c achieved during
the 20% carbohydrate period were retained over the fol-
lowing 6 months (see Table 2).
For the five controls, who never changed diet, there was
no average change over the 18–22 months.
Discussion
The short-term effectiveness of low-carbohydrate diets for
weight reduction is well established [2-6]. Weight reduc-
tion is primarily caused by decreased caloric intake [2-6]
although decreased energy efficiency has also been found
[7]. A high-starch, high-carbohydrate diet excessively
stimulates appetite and disturbs energy balance in
patients with the metabolic syndrome and type 2 diabetes
[8]. A reduction of carbohydrates normalises the balance,
reduces insulin concentrations and favours utilization of
stored fat as fuel as well as significantly reducing insulin
resistance [8]. Weight loss in overweight persons is
improved by a higher proportion of protein, presumably
due to protein's effect on satiety and/or metabolic effi-
ciency [7,9-11]. A reduction in carbohydrates for patients
with type 2 diabetes effectively reduces both fasting and
postprandial glucose as well as HbA1c. These effects can
be independent of weight loss [8,12,13].
Critics of the low-carbohydrate dietary approach usually
point to the lack of long-term studies. The change of diet
described here in combination with the usual diabetes
care has produced long periods of increased well-being in
Percentage changes in HbA1c and bodyweight in 16 obese  patients with type 2 diabetes Figure 2
Percentage changes in HbA1c and bodyweight in 16 
obese patients with type 2 diabetes. The figures are 
plotted 3 months after a change to a 20 % carbohydrate diet 
at which time the reduction in HbA1c was most pronounced.
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Table 1: Effect of diet on weight, BMI, HbA1c and fasting lipids. Sixteen obese patients with type 2 diabetes started at month 0 on a 
diet with the proportions: 20 % carbohydrates, 30 % protein and 50 % fat. The figures shown are before, 3, 6 and 22 months after the 
dietary change
Months 0 3 P* 6 P* 22 P*
Weight (kg) 100.6 ± 14.7 91.9 ± 14.7 <0.001 89.2 ± 14.3 <0.001 92.0 ± 14.0 <0.001
BMI (kg/m2) 36.1 ± 4.2 33.0 ± 4.5 <0.001 32.0 ± 4.3 <0.001 32.9 ± 3.5 <0.001
HbA1c (%) 8.0 ± 1.5 5.9 ± 0.7 <0.001 6.6 ± 1.0 <0.001 6.9 ± 1.1 <0.001
Lipids(mmol/l)
Tot-Chol. 5.6 ± 1.2 5.8 ± 1.1 0.4 6.1 ± 1.1 0.06 5.7 ± 1.2 0.9
HDL-Chol. 1.1 ± 0.2 1.2 ± 0.2 <0.002 1.3 ± 0.2 <0.001 1.3 ± 0.3 <0.001
§ Triglycerides 1.4(1;1,8) 1.2(0.8;1,4 0.01 1.4(0.9;1.7) 0.4 1.4(1.2;1.9) 0.9
Chol/HDL 5.4 ± 1.5 5.0 ± 1.5 0.02 5.0 ± 1.7 0.07 4.6 ± 1.6 <0.001
§ TG/HDL 1.4(0.9;1.7) 1.0(0.6;1.2) 0.003 1.0(0.7;1.5) 0.03 1.3(0.8;1.5) 0.2
§ given as median with 25 and 75 percentiles. * p values are for differences from baseline.
Individual changes in bodyweight in 16 obese patients with  type 2 diabetes Figure 1
Individual changes in bodyweight in 16 obese patients 
with type 2 diabetes. The patients at start changed from a 
high-carbohydrate diet to a diet consisting of 20 % carbohy-
drates, 30 % protein and 50 % fat.
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these patients. It is significant that 44 % of the patients
have had a stable weight or have reduced it further and all
but one had a lower weight at 22 months than at the
beginning of the study. Twenty-five % of the patients had
previously been dieting continuously and another 50 %
had tried to lose weight many times. The reasons they gave
for not continuing their previous weight loss programs
were 1) constant hunger, and 2) no effect on bodyweight
despite strict calorie counting and fat reduction. The lack
of hunger and cravings with the low-carbohydrate diet
may be an important reason for their present success.
Regular self measurement of blood glucose has probably
made it possible for these patients to succeed. Self deter-
mination of blood glucose provides a feed-back mecha-
nism and may be another reason that 44 % of the patients
succeeded in maintaining their weight.
For most insulin-treated patients, we found that it was
necessary to be one step ahead in lowering the insulin
doses, that is, if weight loss stopped, and the patient was
adhering to the diet (as judged by blood glucose values),
even a minor reduction of the insulin dose normally
resulted in continued weight loss and presumably contin-
ued motivation. This close supervision may be another
reason for the patients' initial success.
Improved HbA1c is associated with a reduced incidence of
microvascular and macrovascular complications [14-16].
The original low carbohydrate group had maintained a
significantly lower mean HbA1c for almost 2 years and a
reduced vascular morbidity might therefore be expected in
this group. Similarly, intentional weight loss in type 2 dia-
betes patients is associated with a reduced mortality of
30–40 % [17]. For the average patient each 1 kg weight
loss is associated with 3–4 months prolonged survival
[18] making it likely that the patients described here have
achieved a survival benefit.
At some point following a reduction of bodyweight and
insulin resistance, a decrease of cardiovascular risk would
be expected [19,20]. We have examined the medical
charts for both the original high-carbohydrate group and
the low-carbohydrate group from 3 months after the initi-
ation of the diet therapy – when an effect might be
detected – and forward for episodes of cardiovascular dis-
ease. Three episodes of cardiovascular disease have
occurred among the 5 patients that never changed diet.
The 16 patients in the low-carbohydrate diet group (19
months observation time) and the 7 from the high-carbo-
hydrate diet group that changed diet (10 months observa-
tion time) – totalling 23 patients – have been free of
cardiovascular disease during the follow-up period (p <
0.03. Fischer Exact).
Several recent reviews have made the case for reducing the
carbohydrate load in type 2 diabetes [21-23] or metabolic
syndrome [24] and the low-carbohydrate diet presented
here is clearly effective in many obese people with type 2
diabetes. Because of its effectiveness it should be used
with close clinical supervision in patients on insulin or
oral hypoglycaemic agents.
In summary, a reduced carbohydrate diet is an effective
tool in the management in motivated obese patients with
type 2 diabetes. The effect is generally retained after
almost 2 years. There has been no evidence of a negative
cardiovascular effect among the 16 subjects.
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